Records containing: Squamous Cell Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-12A Phase 1b/2a Two-Part, Open-Label, Multicenter Study to Evaluate the Safety and Pharmacokinetics of OC-001 as Monotherapy and in Combination With an Anti-PD-1/Anti-PD-L1 Antibody in Patients With Selected Locally Advanced or Metastatic Cancers
-
CLINICAL_TRIALS study record update · 2026-01-09A Phase 2 Trial of Intraoperative Fluorescent Angiography to Decrease Pharyngocutaneous Fistula Rates in Patients Undergoing Hypopharyngeal Reconstruction
-
CLINICAL_TRIALS study record update · 2025-12-31A Phase 1B Study of Intralesional Injection of RP1 in Patients With Resectable Cutaneous SCC
-
CLINICAL_TRIALS study record update · 2025-12-30A Multicenter Pilot Study of Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-12-22Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Pilot, Phase 2 Clinical Trial to Evaluate Administration of Cancer-Directed Therapy in the Patient's Homes Versus in Clinic in the Florida Panhandle and Surrounding Areas
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-18Phase I Dose-escalation Study of PEmbrolizumab (MK3475) Anti-PD1 Immune Checkpoint Inhibitor Combined With Radical Chemoradiotherapy in Patients With Stage IV Squamous Cell Carcinoma of the Head and Neck
-
CLINICAL_TRIALS study record update · 2025-12-05A Phase 1b Trial of the IRX-2 Regimen and Durvalumab (MEDI4736), in Patients With Incurable Head and Neck Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-12-02A Pivotal, Single Arm, Open Label Clinical Study to Assess the Safety and Efficacy of Intratumoral Alpha DaRT224 for the Treatment of Immunocompromised Patients With Cutaneous Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-11-21Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
-
CLINICAL_TRIALS study record update · 2025-11-18Screening for Anal Cancer in MSM Using PrEP
-
CLINICAL_TRIALS study record update · 2025-10-14Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-10-08A Phase 1/2a, Open-Label, Dose Escalation and Expansion Study of the Safety and Tolerability of T3011 Administered Via Intratumoral Injection as a Single Agent and in Combination With Intravenous Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-10-02ClinicalTrials.gov study NCT05974410
-
CLINICAL_TRIALS study record update · 2025-09-17Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas
-
CLINICAL_TRIALS study record update · 2025-08-15Phase II Trial of Atezolizumab and Tiragolumab for Patients With Detectable Circulating Tumor DNA After Definitive Treatment for HPV-positive Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-08-08A Phase II, Multicenter, Single-Arm Clinical Trial of Radiotherapy and CeMiPlimAb: Rwlc ImmunoTherapy for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: RAMPART
-
CLINICAL_TRIALS study record update · 2025-08-03A Multi-part, Phase 1, Multi-center, Open-label Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel or Pembrolizumab in Patients With Relapsed or Refractory Esophagogastric Malignancies
-
CLINICAL_TRIALS study record update · 2025-08-03Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-08Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer With No Evidence of Disease on Post-Treatment Imaging
-
CLINICAL_TRIALS study record update · 2025-06-26Perioperative Chemoimmunotherapy With Toripalimab for Sinonasal Cancer
-
CLINICAL_TRIALS study record update · 2025-06-11Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
-
CLINICAL_TRIALS study record update · 2025-06-06Window-of-Opportunity Trial of Nivolumab and BMS986205 in Patients With Squamous Cell Carcinoma of the Head and Neck (CA017-087)
-
CLINICAL_TRIALS study record update · 2025-06-05A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer Including Melanoma and Non-Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-29Phase II Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)
-
CLINICAL_TRIALS study record update · 2025-05-29Phase I Trial With Expansion Cohort of OBP-301 (Telomelysin™) and Definitive Chemoradiation for Patients With Locally Advanced Esophageal and Gastroesophageal Cancer Who Are Not Candidates for Surgery